newsfilter
← Latest News
GlobeNewswire·

Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug

Data from the dose optimization trial expected soonProLectin-M is positioned as the first oral antiviral sugar chemistry drug BOSTON, MASSACHUSETTS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB:BIXT) (the